These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 22799316

  • 21. Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
    Choi EK, Chong A, Ha JM, Jung CK, O JH, Kim SH.
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):73-79. PubMed ID: 28329426
    [Abstract] [Full Text] [Related]

  • 22. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy.
    Karatzas T, Vasileiadis I, Charitoudis G, Karakostas E, Tseleni-Balafouta S, Kouraklis G.
    Hormones (Athens); 2013 Jul; 12(4):529-36. PubMed ID: 24457401
    [Abstract] [Full Text] [Related]

  • 23. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
    Chang YW, Kim HS, Kim HY, Lee JB, Bae JW, Son GS.
    Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
    [Abstract] [Full Text] [Related]

  • 24. BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.
    Ma YJ, Deng XL, Li HQ.
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):591-599. PubMed ID: 26223933
    [Abstract] [Full Text] [Related]

  • 25. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
    Chung SY, Lee JS, Lee H, Park SH, Kim SJ, Ryu HS.
    Acta Cytol; 2013 Aug; 57(3):252-8. PubMed ID: 23636013
    [Abstract] [Full Text] [Related]

  • 26. Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck.
    Koo BS, Choi EC, Park YH, Kim EH, Lim YC.
    J Am Coll Surg; 2010 Jun; 210(6):895-900. PubMed ID: 20510797
    [Abstract] [Full Text] [Related]

  • 27. [Prediction of occult carcinoma in contralateral nodules based on the ultrasonic features of unilateral papillary thyroid carcinoma].
    Yang LM, Li Q, Zhao BW, Lyu JG, Xu HS, Xu LL, Li SY, Gao L, Zhu J.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr 07; 52(4):259-262. PubMed ID: 28441801
    [Abstract] [Full Text] [Related]

  • 28. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
    Dobrinja C, Pastoricchio M, Troian M, Da Canal F, Bernardi S, Fabris B, de Manzini N.
    Int J Surg; 2017 May 07; 41 Suppl 1():S34-S39. PubMed ID: 28506411
    [Abstract] [Full Text] [Related]

  • 29. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC.
    Ann Surg; 2009 May 07; 249(5):840-4. PubMed ID: 19387316
    [Abstract] [Full Text] [Related]

  • 30. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.
    Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R.
    J Clin Oncol; 2009 Jun 20; 27(18):2977-82. PubMed ID: 19414674
    [Abstract] [Full Text] [Related]

  • 31. [Managements of small thyroid nodules with contralateral papillary thyroid microcarcinoma].
    Meng LW, Huang LM, Xu CY, Zhang W.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct 20; 47(10):827-30. PubMed ID: 23302164
    [Abstract] [Full Text] [Related]

  • 32. Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.
    Zheng X, Wei S, Han Y, Li Y, Yu Y, Yun X, Ren X, Gao M.
    Ann Surg Oncol; 2013 Jul 20; 20(7):2266-73. PubMed ID: 23370668
    [Abstract] [Full Text] [Related]

  • 33. [Prediction of occult carcinoma in contralateral nodules for unilateral papillary thyroid carcinoma].
    Wan H, Zhang B, Yan D, Xu Z.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov 20; 49(11):881-4. PubMed ID: 25598363
    [Abstract] [Full Text] [Related]

  • 34. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma.
    Danilovic DL, Lima EU, Domingues RB, Brandão LG, Hoff AO, Marui S.
    Eur J Endocrinol; 2014 Apr 20; 170(4):619-25. PubMed ID: 24468978
    [Abstract] [Full Text] [Related]

  • 35. BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients.
    Zhao H, Liu CH, Lu Y, Liu SZ, Yeerkenbieke P, Cao Y, Xia Y, Gao LY, Liu YW, Liu ZW, Chen SG, Liang ZY, Li XY.
    Oral Oncol; 2024 May 20; 152():106755. PubMed ID: 38547780
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.